Very-Low-Density Lipoprotein of Metabolic Syndrome Modulates Gap Junctions and Slows Cardiac Conduction

Very-low-density lipoproteins (VLDL) is a hallmark of metabolic syndrome (MetS) and each manifestation of MetS is related to atrial fibrillation (AF) risks. Slowed atrial conduction is a mechanism of AF in MetS. We hypothesized that VLDL can modulate and reduce atrial gap junctions. VLDLs were separ...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Lee, Hsiang-Chun, Chen, Chih-Chieh, Tsai, Wei-Chung, Lin, Hsin-Ting, Shiao, Yi-Lin, Sheu, Sheng-Hsiung, Wu, Bin-Nan, Chen, Chu-Huang, Lai, Wen-Ter
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5608762/
https://ncbi.nlm.nih.gov/pubmed/28935953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-11416-5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires